From January to March 2017, the researchers distributed a cross-sectional online survey to all physicians in the Division of General Internal Medicine and Clinical Innovation at NYULH, across 5 different practice settings. A total of 138 (out of 530) responded (26%).
Researchers reviewed clinical trial data to evaluate the efficacy of herpes zoster subunit vaccine in preventing complications, hospitalizations, and deaths.
There were declines in mortality from most categories of infectious diseases, with large differences among US counties. However, over this time there was an increase in mortality for diarrheal diseases.
Result supports the importance of both reducing sitting time and promoting physical activity for preventing lower urinary tract symptoms.
Rotavirus vaccines are effective in reducing rates of acute gastroenteritis and rotavirus hospitalizations among low birth weight and very low birth weight children.
Vaccine-derived immune protection against mumps wanes on average 27 years after vaccination.
Findings confirm that cardiovascular complications related to commonly-administered, live viral vaccination are rare in adults.
Measles vaccination, administered in the recommended sequence, is associated with improved child survival and may have contribute to the achievement of Millennium Development Goal 4.
The estimated cumulative vaccine antigen exposure through age 23 months does not differ significantly for children with vs those without hospital visits for infectious diseases not targeted by vaccines from age 24 to 47 months.
Maternal receipt of influenza and tetanus toxoid, reduced diphtheria toxoid, and Tdap vaccines is not associated with infant hospitalization or death.
Maternal vaccination against pertussis between 27 and 36 weeks of gestation was associated with a high percentage of newborns with protective pertussis antibody concentrations.
The Advisory Committee on Immunization Practices has provided 3 new recommendations to supplement its original 2008 report, as well as a cost-effectiveness analysis from the CDC.
In the overall comparative meta-analyses, the multicomponent meningococcal serogroup B vaccine had increased immunogenicity (short-term and persistent) compared with recombinant meningococcal serogroup B vaccine against strain NZ98/254.
The ACIP has released the 2018 Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger.
The ACIP has released the 2018 Recommended Immunization Schedule for Adults Aged 19 Years or Older.
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- Generic HIV Medicines: Boon or Bust?
- Insulin-Treated Diabetes Reduces Dysglycemia-Related Mortality in Sepsis
- It Costs $2.2 Billion a Year to Treat Antibiotic Resistance
- Pregnancy May Be Independently Associated With Prolonged Detection of Zika Virus RNA
- Tricyclic Antidepressants May Reduce Cirrhosis Risk in Hepatitis C
- Clostridium difficile Infection in the Intensive Care Setting
- Combating Medically Important Antibiotic Use in Food-Producing Animals
- Religious Exemptions vs Mandatory Vaccinations: An Expert Perspective
- 2018 Vaccination Schedule: Adults
- Fingerstick Point-of-Care Test Allows for Single-Visit HCV Diagnoses
- Glecaprevir/Pibrentasvir Highly Efficacious for HCV/HIV Coinfection
- Fluoroquinolone Use May Increase Risk for Aortic Aneurysm and Dissection
- Reduced Risk of Hepatocellular Carcinoma in DAA-Treated HCV Infection
- Paracetamol Overuse During Cold and Flu Season
- C difficile Risk Higher With Stoma Reversal vs Colectomy